vs
Side-by-side financial comparison of HAWTHORN BANCSHARES, INC. (HWBK) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
HAWTHORN BANCSHARES, INC. is the larger business by last-quarter revenue ($21.2M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). On growth, HAWTHORN BANCSHARES, INC. posted the faster year-over-year revenue change (12.2% vs -25.6%). HAWTHORN BANCSHARES, INC. produced more free cash flow last quarter ($22.8M vs $2.2M). Over the past eight quarters, HAWTHORN BANCSHARES, INC.'s revenue compounded faster (9.1% CAGR vs -10.1%).
Hawthorn Bancshares, Inc. is a U.S. regional bank holding company operating through its wholly owned subsidiary Hawthorn Bank. It provides a full range of retail and commercial banking services including deposit products, mortgage loans, small business financing, commercial lending, and wealth management solutions, primarily serving individual customers and small to mid-sized enterprises across local communities in Missouri.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
HWBK vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $18.3M |
| Net Profit | — | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 35.7% | -2.2% |
| Net Margin | — | -3.0% |
| Revenue YoY | 12.2% | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | $0.90 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.2M | $18.3M | ||
| Q3 25 | $20.6M | $15.9M | ||
| Q2 25 | $19.7M | $16.1M | ||
| Q1 25 | $18.8M | $18.9M | ||
| Q4 24 | $18.9M | $24.7M | ||
| Q3 24 | $18.1M | $28.3M | ||
| Q2 24 | $18.2M | $25.8M | ||
| Q1 24 | $17.8M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $6.1M | $-1.8M | ||
| Q2 25 | $6.1M | $-1.5M | ||
| Q1 25 | $5.4M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $4.6M | $1.7M | ||
| Q2 24 | $4.6M | $343.0K | ||
| Q1 24 | $4.5M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 35.7% | -2.2% | ||
| Q3 25 | 36.4% | -9.9% | ||
| Q2 25 | 37.9% | -8.4% | ||
| Q1 25 | 35.2% | -7.2% | ||
| Q4 24 | 29.9% | -2.1% | ||
| Q3 24 | 31.1% | 6.8% | ||
| Q2 24 | 31.2% | 2.0% | ||
| Q1 24 | 30.5% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | 29.8% | -11.0% | ||
| Q2 25 | 31.0% | -9.3% | ||
| Q1 25 | 28.7% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 25.3% | 5.9% | ||
| Q2 24 | 25.5% | 1.3% | ||
| Q1 24 | 25.1% | -7.6% |
| Q4 25 | $0.90 | $-0.01 | ||
| Q3 25 | $0.88 | $-0.05 | ||
| Q2 25 | $0.88 | $-0.05 | ||
| Q1 25 | $0.77 | $-0.04 | ||
| Q4 24 | $0.66 | $-0.02 | ||
| Q3 24 | $0.66 | $0.04 | ||
| Q2 24 | $0.66 | $0.01 | ||
| Q1 24 | $0.63 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.3M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $174.2M | $37.0M |
| Total Assets | $1.9B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.3M | $10.7M | ||
| Q3 25 | $99.9M | $13.6M | ||
| Q2 25 | $100.3M | $12.5M | ||
| Q1 25 | $102.3M | $11.4M | ||
| Q4 24 | $51.0M | $15.7M | ||
| Q3 24 | $54.2M | $12.3M | ||
| Q2 24 | $75.8M | $11.9M | ||
| Q1 24 | $43.5M | $6.6M |
| Q4 25 | $174.2M | $37.0M | ||
| Q3 25 | $164.9M | $37.0M | ||
| Q2 25 | $156.8M | $30.4M | ||
| Q1 25 | $153.4M | $31.5M | ||
| Q4 24 | $149.5M | $32.6M | ||
| Q3 24 | $146.5M | $29.1M | ||
| Q2 24 | $138.2M | $23.5M | ||
| Q1 24 | $136.6M | $20.6M |
| Q4 25 | $1.9B | $57.1M | ||
| Q3 25 | $1.9B | $57.5M | ||
| Q2 25 | $1.9B | $52.6M | ||
| Q1 25 | $1.9B | $54.0M | ||
| Q4 24 | $1.8B | $59.2M | ||
| Q3 24 | $1.8B | $57.1M | ||
| Q2 24 | $1.8B | $53.0M | ||
| Q1 24 | $1.8B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.9M | $2.3M |
| Free Cash FlowOCF − Capex | $22.8M | $2.2M |
| FCF MarginFCF / Revenue | 107.9% | 12.0% |
| Capex IntensityCapex / Revenue | 19.3% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $32.7M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.9M | $2.3M | ||
| Q3 25 | $288.0K | $-1.3M | ||
| Q2 25 | $5.8M | $1.8M | ||
| Q1 25 | $5.7M | $-3.5M | ||
| Q4 24 | $25.6M | $865.0K | ||
| Q3 24 | $9.1M | $4.3M | ||
| Q2 24 | $8.9M | $1.4M | ||
| Q1 24 | $5.6M | $-2.4M |
| Q4 25 | $22.8M | $2.2M | ||
| Q3 25 | $-734.0K | $-1.5M | ||
| Q2 25 | $5.1M | $1.7M | ||
| Q1 25 | $5.5M | $-3.5M | ||
| Q4 24 | $22.6M | $470.0K | ||
| Q3 24 | $8.1M | $4.1M | ||
| Q2 24 | $8.4M | $1.2M | ||
| Q1 24 | $5.1M | $-2.5M |
| Q4 25 | 107.9% | 12.0% | ||
| Q3 25 | -3.6% | -9.6% | ||
| Q2 25 | 25.9% | 10.5% | ||
| Q1 25 | 29.1% | -18.8% | ||
| Q4 24 | 119.7% | 1.9% | ||
| Q3 24 | 44.9% | 14.4% | ||
| Q2 24 | 46.2% | 4.5% | ||
| Q1 24 | 28.5% | -11.1% |
| Q4 25 | 19.3% | 0.5% | ||
| Q3 25 | 5.0% | 1.4% | ||
| Q2 25 | 3.3% | 1.0% | ||
| Q1 25 | 1.5% | 0.3% | ||
| Q4 24 | 15.9% | 1.6% | ||
| Q3 24 | 5.5% | 0.7% | ||
| Q2 24 | 3.0% | 1.1% | ||
| Q1 24 | 3.1% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.94× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.99× | 2.57× | ||
| Q2 24 | 1.93× | 4.20× | ||
| Q1 24 | 1.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HWBK
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
